Telix Pharmaceuticals TLX
NASDAQ TLX
$9.23 +0.20 (+2.21%)
As of: Oct 28, 2026 · 2:32 PM EDT

Telix Pharmaceuticals (TLX) Retained Earnings (2023 - 2026)

Updated

Telix Pharmaceuticals (TLX) reported Retained Earnings of -$110.9 million for the quarter ended Jun 30, 2026.

Analysis

Telix Pharmaceuticals (TLX) Retained Earnings (2023 - 2026) Analysis & Trends

As of Dec 31, 2025, Telix Pharmaceuticals posted Retained Earnings of -$154.54 million.

  • By year, Retained Earnings came in at -$304.93 million in the year ended Dec 31, 2024 and -$187.12 million in the year ended Dec 31, 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Eli Lilly 1,147.89 Bn 1,116.48 Bn 19.71 Bn 31.89 Bn
2 Johnson & Johnson 654.22 Bn 574.08 Bn 17.30 Bn 168.36 Bn
3 AbbVie 508.68 Bn 481.79 Bn 12.70 Bn -17.33 Bn
4 Merck 347.00 Bn 301.38 Bn 12.21 Bn 63.27 Bn
5 Novartis Ag 302.29 Bn 275.53 Bn - -
6 Astrazeneca 263.02 Bn 236.71 Bn 12.86 Bn 12.59 Bn
7 Amgen 243.40 Bn 198.80 Bn 7.24 Bn -22.28 Bn
8 Gilead Sciences 197.97 Bn 172.17 Bn 6.22 Bn 2.20 Bn
9 Pfizer 166.90 Bn 113.54 Bn 10.94 Bn 112.09 Bn
10 Telix Pharmaceuticals 3.12 Bn 2.08 Bn - -110.90 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -110.90 Mn
Dec 31, 2025 -154.54 Mn
Dec 31, 2024 -132.46 Mn
Dec 31, 2023 -179.99 Mn
API Access

Telix Pharmaceuticals Retained Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=retained-earnings&ticker=TLX&period=max&api_key=YOUR_API_KEY